Emerging research highlighted by Hemp Gazette suggests that more than half of individuals with inflammatory bowel disease (IBD) who use cannabis or CBD products report relief from symptoms such as abdominal pain, stress, anxiety, depression, and nausea. The findings indicate that patients living with chronic conditions like Crohn’s disease and ulcerative colitis are increasingly turning
READ MORE
A new placebo-controlled trial presented at the American Headache Society reveals that vaporized cannabis—especially a combination of THC and CBD—offers significant relief for migraine sufferers. In the study, over two-thirds of participants reported pain relief two hours after using either THC (68.9%) or a THC–CBD combination (67.2%), while only 46.6% experienced relief with a placebo.
READ MORE
A recent study from Case Western Reserve University reveals that a strong majority of patients with inflammatory bowel disease (IBD) believe cannabis and CBD oil significantly help manage their symptoms. Over half of IBD patients surveyed reported current cannabis use, with 63.2% saying it eased symptoms like abdominal pain, stress, and nausea. Similarly, 56.6% found
READ MORE
A coalition of 45 leading health and advocacy organizations, including Americans for Safe Access, the National Multiple Sclerosis Society, and the Epilepsy Foundation of America, is urging Congress to maintain federal protections for state medical marijuana programs. These groups sent a letter to House and Senate appropriations leaders, emphasizing that the annual spending bill should
READ MORE
A new study challenges the widespread belief that cannabis helps people with insomnia get more rest. Researchers from Macquarie University and the University of Sydney found that a single oral dose of a medicinal cannabis product actually reduced total sleep time and REM sleep in adults diagnosed with insomnia. The pilot study involved 20 participants,
READ MORE
Three Louisville-area business owners have filed suit against the state of Kentucky, claiming the process for awarding medical marijuana business licenses was opaque and potentially unlawful. The plaintiffs, represented by attorney Greg Troutman, argue that the state’s use of a lottery—conducted by the Kentucky Lottery in April—was never authorized by lawmakers and lacked proper oversight.
READ MORE
